Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (1121-1130 of 5,911) with videos related to

Pageof 592
Sort By:
The Prostate|January 1, 1987
Immunoscintigraphic evaluation of lymph node involvement in prostatic carcinomaP Vihko, M Kontturi, O Lukkarinen, et al.
The Prostate|November 3, 2020
TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancerKosj Yamoah, Priti Lal, Shivanshu Awasthi, et al.
The Prostate|December 24, 2022
A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamideMaría P Fernandez-Perez, Enrique Perez-Navarro, Teresa Alonso-Gordoa, et al.
The Prostate|December 24, 2022
Importance of magnetic resonance imaging and prostate-specific membrane antigen PET-CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancerPawel Rajwa, David Pfister, Constantin Rieger, et al.
The Prostate|January 1, 1987
Stress stimuli-induced histopathological changes in the prostate: an experimental study in the ratL Gatenbeck, A Aronsson, S Dahlgren, et al.
The Prostate|January 20, 2023
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapyTakafumi Yanagisawa, Kenichi Hata, Shintaro Narita, et al.
The Prostate|January 4, 2023
Transcriptomic profiling and genomic rearrangement landscape of Nigerian prostate cancerYusuph Mavura, Hanbing Song, Jamie Xie, et al.
The Prostate|June 2, 2022
Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk levelGabriele Sorce, Benedikt Hoeh, Rocco S Flammia, et al.
The Prostate|June 2, 2022
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastasesAlex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth, et al.
The Prostate|November 29, 2022
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meetingAndrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala, et al.
Pageof 592

Showing results (1121-1130 of 5,911) with videos related to

Sort By:
Pageof 592
The Prostate|January 1, 1987
Immunoscintigraphic evaluation of lymph node involvement in prostatic carcinomaP Vihko, M Kontturi, O Lukkarinen, et al.
The Prostate|November 3, 2020
TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancerKosj Yamoah, Priti Lal, Shivanshu Awasthi, et al.
The Prostate|December 24, 2022
A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamideMaría P Fernandez-Perez, Enrique Perez-Navarro, Teresa Alonso-Gordoa, et al.
The Prostate|December 24, 2022
Importance of magnetic resonance imaging and prostate-specific membrane antigen PET-CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancerPawel Rajwa, David Pfister, Constantin Rieger, et al.
The Prostate|January 1, 1987
Stress stimuli-induced histopathological changes in the prostate: an experimental study in the ratL Gatenbeck, A Aronsson, S Dahlgren, et al.
The Prostate|January 20, 2023
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapyTakafumi Yanagisawa, Kenichi Hata, Shintaro Narita, et al.
The Prostate|January 4, 2023
Transcriptomic profiling and genomic rearrangement landscape of Nigerian prostate cancerYusuph Mavura, Hanbing Song, Jamie Xie, et al.
The Prostate|June 2, 2022
Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk levelGabriele Sorce, Benedikt Hoeh, Rocco S Flammia, et al.
The Prostate|June 2, 2022
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastasesAlex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth, et al.
The Prostate|November 29, 2022
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meetingAndrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala, et al.
Pageof 592